# Double-blind, Placebo-control, Study to Evaluate the Safety and Pharmacokinetics of CT-044 HCl, in Healthy Volunteers

> **NCT04175743** · PHASE1 · UNKNOWN · sponsor: **Lotus Clinical Research, LLC** · enrollment: 21 (actual)

## Conditions studied

- Acute Pain
- Pain, Acute
- Surgery
- Neuropathy

## Interventions

- **DRUG:** CT-044 HCl

## Key facts

- **NCT ID:** NCT04175743
- **Lead sponsor:** Lotus Clinical Research, LLC
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-12-04
- **Primary completion:** 2020-08
- **Final completion:** 2020-09
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2020-07-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04175743

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04175743, "Double-blind, Placebo-control, Study to Evaluate the Safety and Pharmacokinetics of CT-044 HCl, in Healthy Volunteers". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04175743. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*